Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 1
2017 1
2019 2
2020 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Endometrial carcinoma in a 14-year-old: A case report.
Uda H, Kitai M, Kogiku A, Kobayashi A, Sakuma T, Nagao S, Yamaguchi S. Uda H, et al. Among authors: kogiku a. Gynecol Oncol Rep. 2019 May 16;29:7-9. doi: 10.1016/j.gore.2019.05.006. eCollection 2019 Aug. Gynecol Oncol Rep. 2019. PMID: 31193481 Free PMC article.
Primary localized amyloidosis of the uterine cervix during pregnancy.
Takimoto Y, Kogiku A, Konda E, Samoto T, Ishihara M, Yamashita T. Takimoto Y, et al. Among authors: kogiku a. J Obstet Gynaecol Res. 2020 May;46(5):787-790. doi: 10.1111/jog.14218. Epub 2020 Feb 19. J Obstet Gynaecol Res. 2020. PMID: 32077184
A phase II study of the combination chemotherapy of bevacizumab and gemcitabine in women with platinum-resistant recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer.
Nagao S, Kogiku A, Suzuki K, Shibutani T, Yamamoto K, Jimi T, Kitai M, Shiozaki T, Matsuoka K, Yamaguchi S. Nagao S, et al. Among authors: kogiku a. J Ovarian Res. 2020 Feb 7;13(1):14. doi: 10.1186/s13048-020-0617-y. J Ovarian Res. 2020. PMID: 32028974 Free PMC article. Clinical Trial.
A preoperative low cancer antigen 125 level (≤25.8 mg/dl) is a useful criterion to determine the optimal timing of interval debulking surgery following neoadjuvant chemotherapy in epithelial ovarian cancer.
Morimoto A, Nagao S, Kogiku A, Yamamoto K, Miwa M, Wakahashi S, Ichida K, Sudo T, Yamaguchi S, Fujiwara K. Morimoto A, et al. Among authors: kogiku a. Jpn J Clin Oncol. 2016 Jun;46(6):517-21. doi: 10.1093/jjco/hyw029. Epub 2016 Mar 13. Jpn J Clin Oncol. 2016. PMID: 26977055